Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43356

CCS Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The CCS Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the CCS gene in the human Raji B lymphocyte line. CCS functions as a copper chaperone that specifically delivers copper to superoxide dismutase 1 (SOD1), activating its superoxide-dismutating activity. Loss of CCS impairs SOD1 maturation, leading to superoxide accumulation and increased oxidative stress. This model is well-suited for investigations of SOD1-dependent antioxidant defense, amyotrophic lateral sclerosis (ALS), copper metabolism disorders, and chaperone-targeted therapies. Key applications include Western blotting, co-immunoprecipitation of CCS-SOD1 complexes, SOD1 enzymatic activity assays, and flow cytometry-based ROS detection.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    CCS

    Gene Identifier

    NCBI Gene ID 9973

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCS Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Raji B lymphocyte line, designed for loss-of-function studies of the CCS gene. This product consists of a mixed population of cells carrying targeted disruptions in the CCS locus, enabling interrogation of CCS-dependent pathways without clonal selection. The knockout model provides a physiologically relevant system to dissect the role of the copper chaperone for superoxide dismutase (CCS) in copper delivery and antioxidant defense.

Raji is an EBV-positive human Burkitt lymphoma-derived B lymphocyte model widely used in immunology, oncology, and signal transduction research. These suspension cells exhibit robust growth and are amenable to functional assays, including flow cytometry, immunoprecipitation, and biochemical analysis. Raji cells express B-cell markers and are commonly used to study B-cell receptor signaling, apoptosis, and oncogene function. The well-characterized EBV-transformed background and accessible multi-omics data offer a defined genetic context for investigating cellular stress responses, metal homeostasis, and lymphoma biology.

CCS encodes a metallochaperone that specifically delivers copper ions to cytosolic SOD1, an essential step for SOD1 enzymatic maturation. In the copper loading cycle, CCS interacts with SOD1 and copper ions, promoting formation of the active Cu,Zn-SOD1 homodimer. Once activated, SOD1 catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide, thereby mitigating oxidative stress. CCS expression and copper delivery are responsive to intracellular copper levels and oxidative conditions, influenced by metal-responsive transcription factors. Disruption of CCS therefore impairs SOD1 activation, leading to accumulation of superoxide and enhanced susceptibility to oxidative damage. This knockout model provides a clean background for examining the CCS-SOD1 axis in the absence of compensatory mechanisms.

Within the Raji B lymphocyte context, CCS knockout offers a unique opportunity to explore how copper chaperone deficiency modulates redox balance, cell survival, and signaling in a lymphoma-derived line. B lymphocytes rely on tight regulation of reactive oxygen species for proliferation, differentiation, and apoptosis, making them sensitive to perturbations in antioxidant defenses. The CCS knockout polyclonal population enables researchers to dissect the contribution of CCS-dependent SOD1 activity to overall cellular resistance to oxidative insults. This platform can also evaluate the interplay between copper homeostasis and lymphomagenesis, and the impact of impaired CCS function on B-cell signaling.

Typical applications include Western blotting and co-immunoprecipitation to assess CCS-SOD1 interaction, SOD1 enzymatic activity assays, and flow cytometric detection of reactive oxygen species. Cell viability assays under oxidative stress conditions (e.g., paraquat or hydrogen peroxide) quantify CCS-dependent cytoprotection. This model is suitable for studying ALS-linked SOD1 dysregulation, copper metabolism disorders, and chaperone-targeted therapies. For additional information or to inquire about custom services, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)